0001354457-13-000223.txt : 20131127
0001354457-13-000223.hdr.sgml : 20131127
20131127094006
ACCESSION NUMBER: 0001354457-13-000223
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20131127
DATE AS OF CHANGE: 20131127
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0000722104
SAVIENT PHARMACEUTICALS INC
000-15313
00 Crossing Boulevard, 3rd Floor
Bridgewater
NJ
NEW JERSEY
08807
732 418-9300
Common stock
17 CFR 240.12d2-2(b)
Amy Horton
Associate General Counsel
2013-11-27
EX-99.25
2
svntdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
November 27, 2013, Savient Pharmaceuticals Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Savient Pharmaceuticals Inc.
(the Company), effective at the opening of the
trading session on December 9, 2013. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5450(a)(1).
The Company was notified of the Staffs determination on
October 8, 2013. The Company did not appeal the Staff
determination to the Hearings Panel, and the Staff
determination to delist the Company became final on
October 17, 2013.